Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2026-01-02 @ 10:33 AM
Study NCT ID:
NCT04980859
Status:
UNKNOWN
Last Update Posted:
2021-07-28
First Post:
2021-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-09
First Submit QC Date:
None
Study First Post Date:
2021-07-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-27
Last Update Post Date:
2021-07-28
Last Update Post Date Type:
ACTUAL